Brought to you by:
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped sway the FDA
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to treat peripheral arterial disease (PAD)—have been made public for the first time at TCT 2023 (Oct.…
Survey suggests venous work less valued than arterial interventions
The majority of more than 300 vascular surgeons who responded to a recent survey indicated that they perceive the management of venous disease to be of less value than that of arterial disease. Investigators Misaki M. Kiguchi, MD, of MedStar…
NESVS 2023: Cambria takes over as New England SVS president
Robert Cambria, MD, recently took over as president of the New England Society for Vascular Surgery (NESVS). He was passed the presidential baton by Sean Roddy, MD, during the NESVS 2023 annual meeting, held in Boston (Oct. 6–8). Cambria is…
Prepare to submit research for VAM 2024
Organizing a Vascular Annual Meeting (VAM) takes a whole lot of time and a whole lot of long-range planning. Thus, members of the SVS Postgraduate Education Committee (PGEC) have already evaluated the 90 submitted proposals (an SVS record) for educational…
Multicenter study points to favourable safety and efficacy of radial access for peripheral interventions
New research examining the safety and efficacy of using radial access for peripheral artery interventions has found that radial access allows early ambulation and same-day discharge with no serious adverse events. These are the conclusions of a study published in…
NESVS 2023: Novel IVC filter retrieval device slashes procedural time and radiation exposure during in vivo experiments, Yale researchers report
An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and radiation exposure, according to data emerging out of in vivo testing at Yale University. The Articulating…
Vascular branding: Determining a vascular surgeon’s value
A vascular surgeon’s value includes far more than direct revenues from procedures performed, said SVS member Robert Tahara, MD, recently. He told surgeons to remember not only these direct revenues, but also the help a surgeon provides other specialties in…
SVS Foundation Board of Directors welcomes two new members to its leadership team
The SVS Foundation’s Board of Directors announced the appointment of two new board members, Edith Tzeng, MD, and Palma Shaw, MD, at the board’s fall meeting in September. Tzeng was approved as the new chair of the Foundation Development Committee. …
Vascular Health Step Challenge emerges as beacon of awareness and action
This September, 533 people put their feet to the ground to raise awareness about peripheral arterial disease (PAD) as part of the SVS Foundation’s Vascular Health Step Challenge. The challenge raises funds and awareness, with participants pledging to walk 60…
SVS webinar covers insights learned from experiences of mass-casualty disasters
A mass shooting in Las Vegas. A bombing at the finish line of the Boston Marathon. A shooting at a Fourth of July parade. Healthcare workers may not be on the actual front line of disasters, but they’re definitely in…